Dermata Therapeutics, Inc. ( DRMAW) - Stock Earnings
Stock symbol DRMAW is outdated, potentially delisted? Maybe it is available on other exchange?
DRMAW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.9 million USD | — USD |
| 2026Q1 | -1.8 million USD | — USD |
| 2026Q2 | -3.0 million USD | — USD |
| 2026Q4 Est. | — | — |
DRMAW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.8 million USD | — USD |
| 2024 | -12.3 million USD | — USD |
| 2025 | -7.6 million USD | — USD |
| 2026 Est. | — | — |
DRMAW
Price: $0
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 203
Market Capitalization: 409